**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 7439-89-6 |IRON | >97 | 231-096-4 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
Exposure to particulates or solution may cause conjunctivitis,
ulceration, and corneal abnormalities. Deposition of particles may
cause corneal discoloration.
Skin:
May cause skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea.
Inhalation:
Inhalation of fumes may cause metal fume fever, which is
characterized by flu-like symptoms with metallic taste, fever,
chills, cough, weakness, chest pain, muscle pain and increased white
blood cell count. May cause lung damage.
Chronic:
Chronic exposure may lead to liver and lung damage. Repeated
exposure may cause pancreatic damage, diabetes, and cardiac
abnormalities.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Immediately flush skin with plenty of water for at least 15 minutes
while removing contaminated clothing and shoes. Get medical aid if
irritation develops or persists.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Get medical aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid if cough or other symptoms appear.
Notes to Physician:
Antidote:
The use of Deferoxamine as a chelating agent should be determined
only by qualified medical personnel.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Dusts at sufficient concentrations can form
explosive mixtures with air. Combustion generates toxic fumes.
Extinguishing Media:
Use only graphite powder, soda ash, powdered sodium chloride, or an
appropriate metal-fire-extinguishing dry powder.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Sweep up or absorb material, then place into a suitable clean, dry,
closed container for disposal. Avoid generating dusty conditions.
Remove all sources of ignition.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. Avoid contact with eyes, skin, and
clothing. Keep container tightly closed. Avoid ingestion and
inhalation.
Storage:
Keep from contact with oxidizing materials. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use process enclosure,
local exhaust ventilation, or other engineering controls to control
airborne levels.
Exposure Limits
CAS# 7439-89-6:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear impervious gloves.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: black
Odor: None reported.
pH: Not available.
Vapor Pressure: 1 mm Hg @ 1787C
Viscosity: Not available.
Boiling Point: 3000 deg C
Freezing/Melting Point: 1535 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Insoluble.
Specific Gravity/Density: 7.86 g/cm3
Molecular Formula: Fe
Molecular Weight: 55.84
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures. Decomposes when
heated. Oxidizes when exposed to air.
Conditions to Avoid:
Incompatible materials, moisture, exposure to air, excess heat.
Incompatibilities with Other Materials:
Acetaldehyde, ammonium peroxodisulfate, chloroformamidinium, chloric
acid, ammonium nitrate, halogens, dinitrogen tetroxide, nitryl
fluoride, polystyrene, sodium acetylide, potassium dichromate,
peroxyformic acid, nitryl fluoride, sulfuric acid, sodium carbide.
Hazardous Decomposition Products:
Oxides of iron.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 7439-89-6: NO4565500 NO8225000
LD50/LC50:
CAS# 7439-89-6: Oral, rat: LD50 = 30 gm/kg.
Carcinogenicity:
IRON -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 7439-89-6: 0
Canada
CAS# 7439-89-6 is listed on Canada's DSL List.
CAS# 7439-89-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 7439-89-6 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 3/18/1998 Revision #3 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
2-(Piperidylmethyl)-1-Cyclohexanone Hydrochloride, 98%
| 6966-09-2 |
|
Fluorosilicic Acid (25 Wt % Aqueous Solution)
| 7732-18-5 |
|
(S)-(-)-Bupivacaine hydrochloride, 99%
| 27262-48-2 |
|
6,7-Diethoxy-3,4-Dihydroisoquinoline-1(2H)-Thione, 98%
| 0-01-1 |
|
Sodium phosphate, dibasic anhydrous, reagent ACS
| 7558-79-4 |
|
1-Nonanol
| 143-08-8 |
|
2-Acetyl-6,7-Dimethoxy-1-Methylene-1,2,3,4-Tetrahydroisoquinoline,
| 57621-04-2 |
|
Lithium methoxide, 10% solution in methanol
| 865-34-9 |
|
[(3S)-4-Azabicyclo[4.4.0]Dec-3-yl]-N-(Tert-Butyl)Carboxamide, 99%
| 136465-81-1 |
|
C-Benzylcalix(4)resorcinarene
| 0-01-1 |
|
(S)-(-)-2-(2'-Carbomethoxyethyl)-2-Methyl-Cyclohexanone, 98.5+%
| 112898-44-9 |
|
(S)-(-)-alpha-Amino-gamma-butyrolactone hydrochloride, 98%
| 2185-03-7 |
|
N-Benzylmaleimide
| 1631-26-1 |
|
4-(Methylamino)benzoic acid, 97%
| 10541-83-0 |
|
Ethyl (3S)-3-Hydroxybutyrate, 99%
| 56816-01-4 |
|
Hydrofluoric Acid (48-51%), Reagent ACS
| 7664-39-3 |
|
ETHYL (1R,2S)-2-HYDROXYCYCLOHEXANECARBOXYLATE
| 61586-78-5 |
|
Iodic Acid, Reagent ACS (Crystals), 99.5% (Titr.)
| 7782-68-5 |
|
3-Pyrazolidinone Hydrochloride
| 1752-88-1 |
|
Tritylphenol
| 978-86-9 |
|
4-Hydroxy-2-Methoxybenzaldehyde, 98%
| 18278-34-7 |
|
4-Nitrobiphenyl, 98%
| 92-93-3 |
|
6-Iodo-2-picolin-5-ol, 97%
| 23003-30-7 |
|
Ethyl
| 100491-29-0 |
|
D(+)-Carnitine, 98%
| 541-14-0 |
|
D(+)-Carnitinenitrile Chloride, 97%
| 0-01-1 |
|
5-Amino-o-Cresol, 97%
| 2835-95-2 |
|
Hydrogen Peroxide (30% in Water) (Without Stabilizer), Reagent ACS
| 7722-84-1 |
|
4-Amino-o-Cresol, 97%
| 2635-95-2 |
|
Hydroquinone, p.a.
| 123-31-9 |
|
2,3-Difluoro-6-nitrophenol, 97%
| 82419-26-9 |
|
Hydroxylamine Sulfate, 99%
| 10039-54-0 |
|
Hypophosphorous Acid, 50 wt% Solution in Water
| 7732-18-5 |
|
cis-2-Heptene, 97%
| 6443-92-1 |
|
Imidazole
| 288-32-4 |
|
3-Amino-3-Cyclohexylpropionic Acid, 98%
| 129042-71-3 |
|
3-Fluorophenylacetic Acid, 98%(GC)
| 331-25-9 |
|
3-Benzylaminobutyric Acid, 98%
| 14676-01-8 |
|
4-NITROTHIOPHENOL, TECH., 80+%
| 1849-36-1 |
|
ALPHA,ALPHA-DIPHENYLGLYCINE, 98%
| 3060-50-2 |
|
Zirconium(IV) ethoxide, 99%
| 18267-08-8 |
|
Celite high-purity analytical grade
| 61790-53-2 |
|
2-CYANOETHYLHYDRAZINE, 98%
| 353-07-1 |
|
Pentamethylbenzaldehyde, 96%
| 17432-38-1 |
|
4-Chloro-3-nitrobenzenesulfonic acid, sodium salt, 98% (tlc)
| 17691-19-9 |
|
cis-2-Benzylaminomethyl-1-Cyclohexanol Hydrochloride, 98%
| 77612-17-0 |
|
Iron, electrolytically reduced, reagent (powder)
| 7439-89-6 |
|
1-(Gamma-Hydroxypropyl)-6,7-Dimethoxy-1,2,3,4-Tetrahydroisoquinoline
| 0-01-1 |
|
Iron (III) Oxide, 99.999%, -100 Mesh
| 1309-37-1 |
|
Perfluoroadipic acid hydrate, 98%
| 123334-02-1 |
|
|